Moderna's stock surged 14% on Friday following news of a National Institutes of Health initiative to fast-track cancer research starting in December, modeled on pandemic vaccine development efforts. The public-private partnership will focus on pancreatic, liver, colorectal, and pediatric cancers, potentially accelerating Moderna's mRNA-based cancer therapies like its co-developed melanoma treatment with Merck.
PopVax's open-source COVID-19 vaccine candidate PVX-001 began Phase 1 human trials in Melbourne on August 31, 2026, with 14 participants enrolled by early October and no serious adverse events reported. The broadly-protective vaccine was developed using PopVax's proprietary mRNA-LNP platform and will be made open-source after trial completion to advance the company's mission of developing life-saving vaccines.
Robinhood Chain celebrates its 100th day with growing ecosystem activity, including a milestone partnership between Robinhood and T. Rowe Price to launch the first actively managed stock token on blockchain. Community builders report platform developments, new gameplay mechanics, and ongoing infrastructure improvements despite current market conditions.